Last reviewed · How we verify
NCT06032234: VEGANScreener
Development and Evaluation of a Web-based Diet Quality Screener for Vegans (VEGANScreener)
trial testing This is an observational study in Healthy in 89 participants. Completed in 31 July 2024.
30 March 2024
Quick facts
| Lead sponsor | Isabelle Herter-Aeberli |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 89 |
| Start date | 12 September 2023 |
| Primary completion | 30 March 2024 |
| Estimated completion | 31 July 2024 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- This is an observational study
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Isabelle Herter-Aeberli
Who can join
Adults 18 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this study is to assess the construct validity and criterion validity for associations of the VEGANScreener with nutrient intakes from reference methods and associations with biomarkers of dietary intake. The investigators hypothesize that the screener is a valid tool to assess diet quality in the vegan population. The study will assess construct validity by testing whether the measure relates as it should to other measures (e.g., age, gender, education, SES differences). The investigators will assess concurrent and predictive validity (types of criterion validity) by evaluating associations and agreement between 'gold standards', such as diet records, biomarkers, and multi-metabolite signatures of intake. The investigators will examine associations of vegan diet quality with biomarkers of nutritional status, biomarkers of disease, and anthropometric measures and hypothesize that a higher diet quality in vegans is associated with a more favourable profile among vegans, for example, a lower blood pressure. This study is part of the European VEGANScreener Consortium.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06032234
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of This is an observational study
Trials testing the same drug.
- NCT06591442 — Screening and Prospective Cohort Study of Risk Factors for Enhanced Recovery After Spinal Fusion Surgery in Advanced Age · enrolling by invitation
- NCT06861205 — Development and Evaluation of a Web-based Diet Quality Screener for Vegans - BELGIUM · active not recruiting
- NCT05621122 — Pro-Vegetarian Diets, Microbial/Metabolite Profiles and Cancer · unknown
- NCT05570370 — Eardream Data Collection in Colombia Supported by ADDF · unknown
- NCT05320471 — Eardream Data Collection in Switzerland Supported by ADDF · unknown
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Isabelle Herter-Aeberli trials
Trials by the same sponsor.
- NCT06655909 — Serum Ferritin Concentration in Kenyan Women and Their Preschool Children at Which the Body Begins to Upregulate Iron Ab · NA · completed
- NCT05788172 — Measuring Menstrual Iron Loss Using the Iron Isotope Dilution Technique · completed
- NCT05697367 — Swiss Childhood Health and Nutrition Survey 2023 · completed
- NCT05580783 — Iron Absorption and Variations of Iron Status, Hepcidin, Inflammation and Sex Hormones During the Menstrual Cycle · NA · completed
- NCT04524013 — Swiss National Iodine Survey 2020 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06032234 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Isabelle Herter-Aeberli
- Last refreshed: 3 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06032234.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing